How to Get Off Adderall Safely: Taper and Timeline

Stopping Adderall safely almost always means tapering gradually under medical supervision rather than quitting all at once. There is no single universally agreed-upon schedule, because the right pace depends on your dose, how long you have been taking the medication, and how your body responds to each reduction. What the evidence does make clear is that abrupt discontinuation can trigger a cluster of withdrawal symptoms, and that a slow, supervised step-down minimizes their intensity and reduces the chance of relapse or rebound.

Why Tapering Matters

Adderall is a mix of amphetamine salts, and your brain adjusts to its presence over weeks and months of use. When the drug is suddenly removed, those adjustments do not reverse overnight. Animal research shows that amphetamine withdrawal leads to a sharp drop in the activity of dopamine-producing neurons. In one study, this activity fell substantially within 18 hours of the last dose and did not return to normal for roughly 72 hours.¹ That temporary dopamine shortfall is a big part of why people feel flat, exhausted, and unmotivated after stopping.

There is also a distinction between withdrawal and rebound. Withdrawal involves new symptoms that were not present before treatment. Rebound is the return of the original symptoms you were treating, sometimes at greater severity than before you ever started medication.² When you stop Adderall cold turkey, both can hit at the same time: you feel the withdrawal crash and your ADHD symptoms flood back, often worse than you remember. A gradual taper gives your brain time to readjust, reducing the overlap and making each phase more manageable.

What Withdrawal Actually Feels Like

Amphetamine withdrawal has been studied far less than withdrawal from alcohol or opioids, but the evidence that exists paints a consistent picture. The hallmark symptom is intense craving, which researchers have identified as one of the primary drivers of relapse.³ Beyond craving, the most commonly reported symptoms include fatigue, increased sleep, depressed mood, irritability, and difficulty concentrating.

The emotional dimension tends to surprise people. Withdrawal from chronic amphetamine use produces what researchers call an anhedonic state, a blunted ability to feel pleasure or motivation. Animal studies have found that this drop in motivated behavior after amphetamine cessation is both immediate and persistent, outlasting the withdrawal period from other stimulants like nicotine.⁴ In practical terms, that means you should expect a stretch of time where things that normally feel rewarding just do not register the same way. This is not a personal failing; it is a predictable neurological adjustment.

The overall symptom profile is similar to what has been documented in cocaine withdrawal, according to earlier research that compared the two.⁵ Both follow a pattern of an initial crash, then a longer period of low mood and disrupted sleep before things start to normalize.

The Timeline

Withdrawal from stimulants unfolds in roughly three phases, and knowing what to expect in each one can help you plan around the hardest stretches. A clinical review of psychostimulant withdrawal laid out the phases as acute (the first week), early protracted (weeks two through four), and late protracted (beyond four weeks).⁶

During the acute phase, the first few days tend to be the roughest. Fatigue and hypersomnia dominate early on. You may sleep far more than usual and still feel drained. Mood drops noticeably. For most people, the physical crash peaks somewhere between days two and four, then begins to ease. The dopamine neuron research mentioned earlier found that the sharpest biological dip resolved within about three days, which aligns with what patients generally report: the worst of the physical exhaustion starts to lift by the end of the first week.

The early protracted phase, weeks two through four, is where the emotional and cognitive symptoms become the main challenge. Concentration difficulties return in full, and they can feel worse than they were before you started Adderall, partly because you are comparing your current state to how you functioned on medication. Mood swings, low motivation, and lingering fatigue are common. Cravings tend to flare during this period as well, especially when you face tasks that Adderall used to make easier.

The late protracted phase varies enormously from person to person. Some people feel mostly back to baseline within six to eight weeks. Others describe subtle motivational or mood changes that persist for a few months, gradually fading. The duration depends heavily on how long you were on Adderall, what dose you were taking, and your individual brain chemistry. People who used the medication at prescribed therapeutic doses for ADHD generally have a shorter and less severe protracted phase than those who used higher doses or took the drug without a prescription.

How a Taper Typically Works

The general principle is straightforward: reduce your dose in small steps over weeks or months, giving yourself time at each new dose to stabilize before making the next cut. In practice, though, the specific schedule is something your prescriber should tailor to you rather than something you should try to follow from a template you found online.

A common approach is to reduce by a small fraction of your current dose every one to two weeks. For someone on a moderate daily dose, that might mean shaving off a small amount and staying at that level for a couple of weeks to see how you feel, then reducing again. Some prescribers prefer percentage-based reductions, where each step is a proportion of the dose you are currently on rather than a fixed number. This means the cuts get smaller as the dose gets lower, which matches the way withdrawal often intensifies at the tail end of a taper. The last stretch, going from a low dose to nothing, is frequently the step people find most difficult, and it sometimes helps to slow the schedule down during that final phase.

There are no large randomized trials defining the optimal Adderall taper protocol. One ongoing study examining lisdexamfetamine (a closely related stimulant) for managing acute methamphetamine withdrawal is using a seven-day schedule that starts at a higher dose and reduces by a fixed amount each day.⁷ That kind of rapid step-down is designed for supervised inpatient withdrawal from illicit stimulant use and is much faster than what would be appropriate for someone discontinuing a prescribed ADHD medication at home. It does, however, illustrate the principle that even researchers studying withdrawal think a gradual reduction is preferable to stopping all at once.

If you are on an extended-release formulation, your prescriber might switch you to an equivalent immediate-release dose first, since immediate-release pills come in smaller increments and allow finer adjustments. This is not always necessary, but it gives more flexibility in the later stages of the taper when the dose reductions need to be very small.

Medications and Therapy During the Process

One frustrating reality is that there is no approved medication specifically for amphetamine withdrawal. A Cochrane review found only four small randomized trials that even attempted to test pharmacological treatments for this problem. Two studies examined a drug called amineptine, which showed some benefit in keeping people in treatment and improving their overall clinical picture, but did not directly reduce withdrawal symptoms or cravings compared to placebo. Two studies tested mirtazapine, an antidepressant, with mixed results: one suggested it might help with anxiety and hyperarousal during withdrawal, while the other found no benefit over placebo.³ The evidence base, in other words, is thin.

A broader review of psychostimulant withdrawal management identified a few candidates that showed potential across different phases: mirtazapine, naltrexone, and bupropion have all been investigated, along with non-drug approaches like repetitive transcranial magnetic stimulation.⁶ None of these has strong enough evidence to count as a standard treatment, but your doctor might consider one of them if your withdrawal symptoms are severe, particularly if depression or anxiety becomes a major problem.

Therapy has a stronger track record. Cognitive behavioral therapy has demonstrated effectiveness for substance use issues both as a standalone treatment and alongside other approaches.⁸ For stimulants specifically, research on CBT and contingency management has found that even brief courses of CBT are associated with meaningful reductions in use.⁹ If you were using Adderall as prescribed for ADHD, CBT can also help you build non-medication strategies for managing focus and organization, giving you tools to fall back on once the medication is gone.

Practical self-care during withdrawal gets mentioned less in the medical literature, but people who have gone through it consistently describe the same things as helpful: protecting your sleep, keeping physical activity in your routine even when motivation is low, eating regular meals, and reducing obligations during the worst of the acute phase. None of this replaces medical supervision, but it makes the process significantly more tolerable.

The Productivity Fear

One of the biggest barriers to stopping Adderall is the fear of losing the cognitive performance you have come to rely on. This is not an abstract worry. In one analysis of posts from a recovery-oriented online community, nearly half the posts were seeking advice about how to quit, but a striking proportion described fear of withdrawal symptoms and loss of productivity as the things standing in their way.¹⁰

This fear is worth taking seriously because it is partly justified: your cognitive performance will dip during withdrawal, especially in the first few weeks. Tasks that felt effortless on Adderall will feel harder. But there is a distortion baked into this fear, too. When you have been on a stimulant for months or years, your memory of your pre-medication cognitive baseline fades. What you remember is how you perform on the drug, and you measure the withdrawal dip against that artificially enhanced standard. Many people find that once they are fully through the protracted phase, their actual unmedicated functioning is better than they feared, though not identical to their medicated state.

If you are coming off Adderall that was prescribed for ADHD, the productivity concern has an added dimension: you may genuinely need some kind of ongoing ADHD management. Stopping a stimulant does not mean abandoning treatment. Non-stimulant medications like atomoxetine, guanfacine, or viloxazine may be options your prescriber can start while you taper, so you are not going from full treatment to no treatment overnight. The conversation with your doctor should ideally be about switching your management strategy, not just about subtracting a medication.

When You Need to Stop Quickly

Sometimes a gradual taper is not realistic. Pregnancy is the most common example. Research on ADHD medication in pregnancy has noted that stopping treatment or inadequately treating the condition can put both mother and baby at risk, yet continuing amphetamines during pregnancy carries its own uncertainties. There are no well-established rapid-discontinuation protocols for Adderall in pregnancy, and the decision involves weighing competing risks with your prescriber and your obstetrician. In general, clinicians tend to discontinue stimulants when pregnancy is confirmed or planned, sometimes transitioning to non-stimulant options.

Other situations that might require faster-than-ideal discontinuation include serious cardiovascular side effects, the emergence of psychotic symptoms, or significant drug interactions with a new medication you need to start. In these cases, the taper may be compressed into days rather than weeks, and closer medical monitoring is appropriate. Your prescriber might want you to check in more frequently, or in some cases manage the transition in an inpatient setting where symptoms can be observed and treated in real time.

What Patients Wish They Had Known

A large qualitative study that analyzed free-text responses from people who had reduced or stopped psychiatric medications found six recurring themes in their experiences, including the challenges of reducing or stopping medication and areas where patients felt the medical system had let them down.¹¹ The study’s title captures a sentiment that comes up constantly in patient accounts: people wish they had been warned before they started the medication how difficult stopping would be.

This is not meant to scare you. It is meant to set realistic expectations. Many prescribers underplay withdrawal when initiating stimulant therapy, either because they are focused on the benefits of treatment or because they genuinely believe the patient will not experience significant symptoms. And many patients start a taper expecting it to be uncomfortable for a week, then feel blindsided when the cognitive fog and low mood persist into the second month. Knowing the timeline in advance is half the battle, because it lets you distinguish “this is a normal part of the withdrawal trajectory” from “something is going wrong.”

The people who tend to have the smoothest experiences share a few things in common: they communicate openly with their prescriber about what they are feeling at each step, they plan ahead for the hardest phases rather than trying to power through critical work deadlines during the acute crash, and they accept that the taper might need to be adjusted on the fly. A schedule that looked reasonable on paper might feel too aggressive once you are actually in it, and slowing down is not failure. It is the whole point of doing this under supervision.

The Research Gap

If you have been reading between the lines, you may have noticed a pattern: the evidence base for managing stimulant withdrawal is remarkably thin compared to what exists for alcohol, opioids, or even benzodiazepines. Researchers have acknowledged this directly. The Cochrane review on amphetamine withdrawal included only four small trials and concluded that no treatment was clearly superior to placebo for reducing actual withdrawal symptoms.³ Much of the available research focuses on methamphetamine or cocaine rather than prescription amphetamines like Adderall, and the populations studied are typically people with stimulant use disorder rather than ADHD patients discontinuing prescribed medication.

This gap matters for you in a practical way. It means your prescriber is working partly from clinical experience and general pharmacological principles, not from a detailed evidence-based protocol the way they might be when tapering you off an SSRI or a benzodiazepine. That is not a reason to avoid the taper. It is a reason to find a prescriber who has experience with stimulant discontinuation and to be an active participant in adjusting the plan as you go. The science will catch up eventually, but in the meantime, the combination of a careful taper, realistic expectations about the timeline, and good communication with your doctor is the best approach available.